Search results for "Hybrozyme"

Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4

Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4

Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million (approximately 521.
Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Major institutional asset managers are steadily increasing their equity stakes in South Korean pharmaceutical and biotechnology companies, drawn by...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?

Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?

Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous...
Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation

Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation

Alteogen announced on the 12th that it has secured registration with the United States Patent and Trademark Office for...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum

Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum

Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...